Anifrolumab-fnia, an IFNAR1-blocking monoclonal antibody, is now authorized for weekly subcutaneous self-administration in adult SLE alongside corticosteroids, antimalarials, and/or immunosuppressants ...

About 5 million people worldwide live with the autoimmune condition lupus. This condition can cause a range of symptoms, including tiredness, fever, joint pain and a characteristic butterfly-shaped ...

Please provide your email address to receive an email when new articles are posted on . Enpatoran bested placebo in CLASI-50 and CLASI-70 at 16 and 24 weeks. The oral small molecule toll-like receptor ...